There are 109 papers on human immunodeficiency virus infection in aging research: 1 trial and 70 observational studies in people, 1 in animals, 1 in cells, 29 reviews.
109 papers study it26 more mention it82 findings
3 new papers in 30 daysSee all 135 papers on human immunodeficiency virus infection
At a glance
Unsuppressed HIV is linked with shorter lifespan in a study of women; human observational studies also link HIV with higher epigenetic age, lower bone density and greater comorbidity burden. Frailty associations differ with adjustment: a study finds an unadjusted association but no clear link after accounting for social and behavioral factors and comorbidities.
82 findings in 53 papers from 2016 to 2026, 8 of them since May 2026
“After the second dose, the geometric mean titer (GMT) of NAbs was lower in PLWH (46.9, 95% confidence interval [CI] 43.6-50.4) compared to HCs (58.2, 95% CI 53.4-63.5).”
- Human trial1
- Humans70
- Animals1
- Cells1
- In silico3
Effects
34Telomere length
downin humans3no changein humans1
3 studies
Telomere length
downin humans3no changein humans1
Human immunodeficiency virus infection is linked with lower telomere length in humans (ART-naïve HIV-infected vs healthy controls) (P<0.01).
“Both naïve (CD45RA+) and memory (CD45RO+) CD8 T cells in this population had significantly shorter telomere lengths (P<0.01) compared to the HC group.”
HumansART-naïve HIV-infected vs healthy controlsCD8 T cellsmales
Current HIV research
Human immunodeficiency virus infection is linked with lower telomere length in humans (untreated HIV infection) (median -2.12%/year (IQR, -3.48% to -0.76%/year; P = .002)).
“During untreated human immunodeficiency virus (HIV) infection (median observation, 7.7; interquartile range [IQR], 4.7-11] years), TL declined significantly (median -2.12%/year; IQR, -3.48% to -0.76%/year; P = .002).”
Humansuntreated HIV infectionperipheral blood mononuclear cellsmedian 7.7 yearsn = 107
The Journal of infectious diseases
Human immunodeficiency virus infection was not clearly linked with telomere length in humans (between T2 and T3) (201±48 at T2 vs. 186±27 kbp/genome at T3, p=0.244).
“while no differences were observed between T2 and T3 (201±48 at T2 vs. 186±27 kbp/genome at T3, p=0.244).”
Humansbetween T2 and T3peripheral blood
Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion
Aging
Human immunodeficiency virus infection is linked with lower telomere length in humans (between pre-HIV (T1) and immediately post-HIV (T2)) (227±46 at T1 vs. 201±48 kbp/genome at T2, p=0.045).
“Telomere length significantly decreased between T1 and T2 (227±46 at T1 vs. 201±48 kbp/genome at T2, p=0.045)”
Humansbetween pre-HIV (T1) and immediately post-HIV (T2)peripheral blood
Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion
Aging
Frailty
upin humans1no changein humans1OR 1.24
2 studies
Frailty
upin humans1no changein humans1OR 1.24
Human immunodeficiency virus infection was not clearly linked with frailty in humans (adjusted for social and behavioral factors and comorbidities) (OR 1.24, 95% CI 0.84 to 1.81).
“HIV was not significantly associated with prefrailty/frailty (odds ratio = 1.24; 95% confidence interval: = 0.84 to 1.81).”
Humansadjusted for social and behavioral factors and comorbidities
Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study
Journal of acquired immune deficiency syndromes (1999)
Human immunodeficiency virus infection increases frailty in PLWH.
“an increased burden of cardiovascular disease, metabolic and bone disorders, HIV-associated neurocognitive disorder (HAND), non-AIDS-defining cancers, frailty”
Reviewin PLWH
Ageing with HIV Clinical and Organisational Challenges of Care
Journal of Education Health and Sport
Coronary endothelial function
downin humans2
2 studies
Coronary endothelial function
downin humans2
Human immunodeficiency virus infection is linked with worse coronary endothelial function in response to isometric handgrip exercise (CSA -0.78% vs 9.07%; CBF 3.85% vs 26.38%).
“CEF was significantly reduced in PLWH compared to controls despite absence of CAD.”
Humansin response to isometric handgrip exercise
AHA Scientific Sessions 2025 abstract
Human immunodeficiency virus infection is linked with worse coronary endothelial function in humans (compared with individuals without HIV) (significantly lower).
“CEF was significantly lower in PWH as compared with individuals without HIV.”
Humanscompared with individuals without HIV
Coronary artery endothelial function and aging in people with HIV and HIV-negative individuals
American journal of physiology. Heart and circulatory physiology
Epigenetic age
upin humans2
2 studies
Epigenetic age
upin humans2
Human immunodeficiency virus infection is linked with higher epigenetic age in humans (+11.2 years).
“DNAm age in HIV-positive individuals is, on average, 11.2 years higher than HIV study participants at baseline”
Humansperipheral bloodmales
AIDS (London, England)
Human immunodeficiency virus infection increases epigenetic age in people with HIV.
“Longitudinal studies now document how leukocyte telomere attrition and epigenetic aging may be accelerated in people with HIV (PWH)”
Reviewin people with HIV
Perspective: clinical relevance of epigenetic aging and HIV
Epigenomics
Neutralizing antibodies
downin humans1
1 study
Neutralizing antibodies
downin humans1
Human immunodeficiency virus infection decreases neutralizing antibodies in humans (at 28 days after the second vaccination (T1)) (46.9 vs 58.2).
“At 28 days after the second vaccination (T1), the GMT of NAbs was significantly lower in PLWH than in HCs (46.9 [95% CI 43.6–50.4] vs 58.2 [95% CI 53.4–63.5]; P < 0.001), although the seropositivity and seroconversion rates were similar (97.9% vs 100.0%).”
Human trialat 28 days after the second vaccination (T1)6-month post-vaccination follow-up
Journal of virology
Human immunodeficiency virus infection decreases neutralizing antibodies in humans after second dose (GMT 46.9 (95% CI 43.6-50.4) vs 58.2 (95% CI 53.4-63.5)).
“After the second dose, the geometric mean titer (GMT) of NAbs was lower in PLWH (46.9, 95% confidence interval [CI] 43.6-50.4) compared to HCs (58.2, 95% CI 53.4-63.5).”
Human trialafter second dose
Journal of virology
Immune age
downin silico1
1 study
Immune age
downin silico1
Human immunodeficiency virus infection decreases immune age in silico (HIV infection) (delta Age < 0).
“validation in an independent HIV cohort revealed a counter-intuitive "negative aging" phenomenon, where the predicted immune age was significantly lower than chronological age (delta Age less than 0).”
In silicoHIV infection
Estimating Immune Age from B-Cell Receptor Repertoire Using Machine Learning
International Conference on Bioinformatics and Biomedical Technology (ICBBT)
Mitochondrial mass
upin humans1
1 study
Mitochondrial mass
upin humans1
Human immunodeficiency virus infection is linked with higher mitochondrial mass in both total and senescent-like CD4+ and CD8+ T cells in PWH.
“PWH exhibited increased mitochondrial mass and membrane potential in both total and senescent-like CD4+ and CD8+ T cells, particularly in CD8+ T cells from older PWH”
Humansin both total and senescent-like CD4+ and CD8+ T cells in PWHT cells
Virologica Sinica
CD57
upin humans1
1 study
CD57
upin humans1
Human immunodeficiency virus infection is linked with higher CD57 in younger PWH compared to younger HIV-negative individuals.
“younger PWH had an ageing-like CD4+ T-cell profile, with higher CD57, CX3CR1 and TIGIT expression than younger HIV-negative individuals”
Humansin younger PWH compared to younger HIV-negative individualsCD4+ T cells
Virologica Sinica
Bone mineral density
downin humans1
1 study
Bone mineral density
downin humans1
Human immunodeficiency virus infection is linked with lower bone mineral density in humans (HIV infection in older men) (-7.1% [-10.9; -3.2]%).
“Men with HIV (MLWH) had lower radial total vBMD (-7.1% [-10.9; -3.2]%), trabecular vBMD (-11.3% [-16.9%; -5.6%]), and BSIc (-12.0% [-18.7%; -5.4]%) than HIV-negative men.”
HumansHIV infection in older menradiusmalesn = 1,101
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Systemic endothelial function
no changein humans1
1 study
Systemic endothelial function
no changein humans1
Human immunodeficiency virus infection was not clearly linked with systemic endothelial function in humans (measured by EndoPAT) (2.07 vs 2.02, p = 0.85).
“In contrast, there was no significant difference in RHI between PLWH and controls (mean RHI: 2.07 [SD 0.81] vs 2.02 [SD 0.70], p = 0.85).”
Humansmeasured by EndoPAT
AHA Scientific Sessions 2025 abstract
All 34Fewer
Associations
30Frailty
upin humans6OR 1.89
6 studies
Frailty
upin humans6OR 1.89
Human immunodeficiency virus infection is associated with frailty in humans (people living with HIV vs without HIV).
“to report a personal history of cardiovascular diseases; and to be frail.”
Humanspeople living with HIV vs without HIVn = 1,049
HIV medicine
Human immunodeficiency virus infection is associated with frailty in humans (unadjusted) (OR 1.89, 95% CI 1.37 to 2.61).
“HIV was associated with prefrailty/frailty [odds ratio = 1.89; 95% confidence interval = 1.37 to 2.61)”
Humansunadjusted
Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study
Journal of acquired immune deficiency syndromes (1999)
Human immunodeficiency virus infection is associated with frailty in humans (compared with uninfected counterparts).
“PLHIV are increasingly confronted with age-related comorbidities and geriatric syndromes, including frailty and polypharmacy, which occur at a higher prevalence and set in at an earlier age compared with their uninfected counterparts.”
Reviewcompared with uninfected counterparts
An overview of multimorbidity and polypharmacy in older people living with HIV
Geriatrics & gerontology international
Human immunodeficiency virus infection is associated with frailty in humans (HIV) (10.9% (95% CI, 8.1%-14.2%)).
“The overall pooled prevalence of frailty and prefrailty was 10.9% (95% confidence interval [CI], 8.1%-14.2%) and 47.2% (95% CI, 40.1%-54.4%), respectively.”
ReviewHIVn = 6,584
Open forum infectious diseases
Human immunodeficiency virus infection raises the risk of frailty in HIV-infected individuals.
“The clinical expression of the immunosenescence state is an increased prevalence of aging-related non-HIV associated comorbidities and a rising prevalence of frailty occurring earlier than in the general population.”
Reviewin HIV-infected individuals
HIV infection as a cause of accelerated aging and frailty
Revista espanola de geriatria y gerontologia
Human immunodeficiency virus infection is associated with frailty in people with HIV.
“In addition, conditions such as geriatric syndromes including frailty are also seen at higher rates.”
Reviewin people with HIV
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Cardiovascular disease
upin humans3downin humans1
4 studies
Cardiovascular disease
upin humans3downin humans1
Human immunodeficiency virus infection is associated with cardiovascular disease in humans (people living with HIV vs without HIV).
“Compared with participants without HIV, those with HIV were more likely to be male; to report lower education levels and incomes; to be more sedentary; to use tobacco, recreational, and prescription drugs; to report a personal history of cardiovascular diseases; and to be frail.”
Humanspeople living with HIV vs without HIVn = 1,049
HIV medicine
Human immunodeficiency virus infection is linked with a lower risk of cardiovascular disease in humans (compared with controls).
“whereas those of cardiovascular disease, heart failure, ischaemic stroke and hypertension were lower in PLWH.”
Humanscompared with controls
HIV medicine
Human immunodeficiency virus infection raises the risk of cardiovascular disease in PLWH.
“manifests as premature multimorbidity, an increased burden of cardiovascular disease”
Reviewin PLWH
Ageing with HIV Clinical and Organisational Challenges of Care
Journal of Education Health and Sport
Human immunodeficiency virus infection raises the risk of cardiovascular disease in people living with HIV.
“It underscores the high risk of cardiovascular disease, insulin resistance, dyslipidemia, and lipodystrophy in people living with HIV.”
Reviewin people living with HIV
Health science reports
Myocardial infarction
upin humans2
2 studies
Myocardial infarction
upin humans2
Human immunodeficiency virus infection raises the risk of myocardial infarction in humans (odds of MI (4.06)).
“human immunodeficiency virus infection quadrupling odds of MI (4.06)”
Review
World journal of cardiology
Human immunodeficiency virus infection raises the risk of myocardial infarction in people living with HIV (1.2-2-fold).
“Epidemiological studies indicate that PWH have a 1.2-2-fold higher risk of myocardial infarction (MI) and other CVD events compared to HIV-negative individuals.”
Reviewin people living with HIV
Antiviral Drugs in HIV and Cardiovascular Disease: Mechanistic Insights and Clinical Implications
Pharmaceuticals (Basel, Switzerland)
Mortality
upin humans2
2 studies
Mortality
upin humans2
Human immunodeficiency virus infection is linked with a higher risk of mortality in COVID-19 patients until age difference reached 6 years or more.
“PLWH had a significantly higher odds of death compared to non-PLWH until age difference reached 6 years or more”
Humansin COVID-19 patients until age difference reached 6 years or more
AIDS and behavior
Human immunodeficiency virus infection is linked with a higher risk of mortality in humans (at early stage of HIV diagnosis).
“The RR of death from PLWH has decreased with the calendar year, but showed a tendency to rise again after 2014 and was significant at the early stage of HIV diagnosis.”
Humansat early stage of HIV diagnosis
HIV medicine
Non-communicable disease
upin humans1
1 study
Non-communicable disease
upin humans1
Human immunodeficiency virus infection is associated with non-communicable disease in humans (vs. uninfected controls).
“Relative risks (RRs) for NCDs in PLWH were higher than controls in younger age groups.”
Humansvs. uninfected controls
HIV medicine
Human immunodeficiency virus infection is linked with a higher risk of non-communicable disease in humans (adjusted incidence rate ratios) (58.5% vs 36.4%).
“58.5% of PLWH and 36.4% of the controls were diagnosed with at least one NCD.”
Humansadjusted incidence rate ratios
HIV medicine
Multimorbidity burden
upin humans1
1 study
Multimorbidity burden
upin humans1
Human immunodeficiency virus infection is associated with multimorbidity burden in humans (before and after COVID-19).
“PWH consistently had a higher multimorbidity burden than PWoH, and this disparity widened after COVID-19”
Humansbefore and after COVID-19
Open forum infectious diseases
Biological age
upin humans1
1 study
Biological age
upin humans1
Human immunodeficiency virus infection is associated with biological age in humans (compared to HIV-negative individuals) (5 to 7 years).
“people living with HIV are approximately 5 to 7 years biologically older than HIV-negative individuals”
Reviewcompared to HIV-negative individuals
Experimental gerontology
Multimorbidity
upin silico1
1 study
Multimorbidity
upin silico1
Human immunodeficiency virus infection is associated with multimorbidity in people living with HIV.
“more than one-quarter will live with at least three additional chronic conditions”
In silicoin people living with HIVby 2034
Forecasting multimorbidity in aging people with HIV using a microsimulation model
Communications health
Frailty-related fracture
upin humans1
1 study
Frailty-related fracture
upin humans1
Human immunodeficiency virus infection is linked with a higher risk of frailty-related fracture in humans (Medicaid beneficiaries).
“Compared to beneficiaries without NADC or HIV, all groups had significantly higher age-specific incidence of fracture.”
HumansMedicaid beneficiaries
PloS one
Cellular senescence
upin humans1
1 study
Cellular senescence
upin humans1
Human immunodeficiency virus infection is associated with cellular senescence in PWH receiving suppressive ART.
“ageing and HIV infection were associated with T-cell remodelling, characterized by expanded late-differentiated phenotypes and reduced stem-like, homeostatic and costimulatory CD4+ and CD8+ T-cell subsets”
Humansin PWH receiving suppressive ARTCD4+ and CD8+ T cells
Virologica Sinica
All 30Fewer
Trial sponsors
Company36 trialsPhase 45,615 people
Company9 trialsPhase 31,264 people
Company3 trialsPhase 31,469 people
Janssen Research & Development
Company1 trialPhase 358 people
Company1 trialPhase 2/3318 people
Company1 trialPhase 22 people
University of California at Davis
1 trialPhase 437 people
1 trialPhase 46 people
Funding
1 grant since 2016Gouvernement du Canada | Canadian Institutes of Health ResearchCA$1.5K
How this record changed
Summary written from the findings.
Latest
35 papers in 12 monthsApolipoprotein B beyond LDL-cholesterol in predicting Atherosclerotic Cardiovascular Disease risk in high-risk populations
Coronary artery disease and neurocognitive performance among older adults in Uganda
Sarcopenia, its components and fracture risk in people living with human immunodeficiency virus
Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)
Ageing with HIV Clinical and Organisational Challenges of Care
Plasma polyunsaturated fatty acid metabolism associations with bone mineral density and bone turnover in pre- and postmenopausal women living with HIV
Iranian health profile: A secondary study based on the social health tree conceptual model
Bone mineral density and cardiovascular risk: Association in individuals living with HIV
See all 135 papers on human immunodeficiency virus infection